Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity - Archive ouverte HAL
Article Dans Une Revue Translational Oncology Année : 2024

Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity

Résumé

A common feature of bacterial, fungal and cancer cell populations upon treatment is the presence of tolerant and persistent cells able to survive, and sometimes grow, even in the presence of usually inhibitory or lethal drug concentrations, driven by non-genetic differences among individual cells in a population. Here we review and compare data obtained on drug survival in bacteria, fungi and cancer cells to unravel common characteristics and cellular pathways, and to point their singularities. This comparative work also allows to cross-fertilize ideas across fields. We particularly focus on the role of gene expression variability in the emergence of cell-cell nongenetic heterogeneity because it represents a possible common basic molecular process at the origin of most persistence phenomena and could be monitored and tuned to help improve therapeutic interventions.
Fichier principal
Vignette du fichier
2024, El Meouche et al, Drug tolerance and persistence in bacteria, fungi and cancer cells, Role of non-genetic heterogeneity.pdf (1.02 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04720374 , version 1 (03-10-2024)

Licence

Identifiants

Citer

Imane El Meouche, Paras Jain, Mohit Kumar Jolly, Jean-Pascal Capp. Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity. Translational Oncology, 2024, 49, ⟨10.1016/j.tranon.2024.102069⟩. ⟨hal-04720374⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More